Qube Research & Technologies (QRT)
BHVN

Qube Research & Technologies (QRT)’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-115,005
Closed -$17.4M – 3236
2022
Q3 		$17.4M Buy
115,005
+108,582
+1,691% +$16.1M 0.1% 270
2022
Q2 		$936K Buy
+6,423
New +$820K 0.01% 1136
2021
Q3 		– Sell
-26,937
Closed -$2.62M – 3075
2021
Q2 		$2.62M Buy
+26,937
New +$2.19M 0.03% 603

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BHVN Position: Q4 2022 in Review

Qube Research & Technologies (QRT) sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 115,005 shares — an estimated $17.4M sold.

Qube Research & Technologies (QRT) first reported a position in BHVN in Q2 2021 and held it in 3 quarters. The position peaked at $17.4M in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Qube Research & Technologies (QRT) reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 115,005 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $17.4M.
  • Qube Research & Technologies (QRT) first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2021 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Biohaven Pharmaceutical Holding Company Ltd. position peaked at $17.4M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2022, filed 14 Feb 2023.